We are live on ! Find out more
CF

Cantor Fitzgerald Portfolio holdings

AUM $6.78B
1-Year Est. Return 29.01%
This Fund
S&P 500
This Quarter Est. Return
+7.21%
1 Year Est. Return
+29.01%
3 Year Est. Return
+173.81%
5 Year Est. Return
10 Year Est. Return
AUM
$4.71B
AUM Growth
+$53M
Cap. Flow
-$971M
Cap. Flow %
-20.64%
Top 10 Hldgs %
15.17%
Holding
850
New
129
Increased
145
Reduced
185
Closed
179

Sector Composition

Rank Sector Weight
1 Financials 25.53%
2 Technology 16.39%
3 Healthcare 9.58%
4 Industrials 6.86%
5 Consumer Discretionary 6.47%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXAC
201
DELISTED
C5 Acquisition Corporation
CXAC
$7.31M 0.16%
700,000
SRPT icon
202
Sarepta Therapeutics
SRPT
$1.64B
$7.3M 0.16%
52,984
+8,380
+19% +$1.09M
NKE icon
203
Nike
NKE
$64.1B
$7.04M 0.15%
57,400
WM icon
204
Waste Management
WM
$95B
$7.01M 0.15%
42,931
-92,945
-68% -$14.2M
SHYL icon
205
Xtrackers Short Duration High Yield Bond ETF
SHYL
$266M
$6.87M 0.15%
157,294
-1,696
-1% -$73.4K
PRLH
206
DELISTED
Pearl Holdings Acquisition Corp Class A Ordinary Shares
PRLH
$6.86M 0.15%
656,979
ACHC icon
207
Acadia Healthcare
ACHC
$2.52B
$6.85M 0.15%
94,840
SOAR icon
208
Volato Group
SOAR
$6.82M
$6.84M 0.15%
26,246
QCOM icon
209
Qualcomm
QCOM
$164B
$6.74M 0.14%
52,810
-129
-0.2% -$16K
GFGD
210
DELISTED
The Growth for Good Acquisition Corporation Class A Ordinary Shares
GFGD
$6.7M 0.14%
654,922
RCFA
211
DELISTED
Perception Capital Corp. IV
RCFA
$6.56M 0.14%
628,672
-203,100
-24% -$2.11M
ARYE
212
DELISTED
ARYA Sciences Acquisition Corp V Class A Ordinary Shares
ARYE
$6.47M 0.14%
632,668
CRWD icon
213
CrowdStrike
CRWD
$183B
$6.42M 0.14%
187,232
-160
-0.1% -$4.63K
KNSW
214
DELISTED
KnightSwan Acquisition Corporation
KNSW
$6.42M 0.14%
616,546
PPYA
215
DELISTED
Papaya Growth Opportunity Corp. I Class A Common Stock
PPYA
$6.29M 0.13%
612,500
+212,500
+53% +$2.19M
VOD icon
216
Vodafone
VOD
$37.1B
$6.23M 0.13%
+564,127
New +$6.43M
FTEC icon
217
Fidelity MSCI Information Technology Index ETF
FTEC
$18.9B
$6.17M 0.13%
54,137
-2,310
-4% -$242K
PLMJ
218
DELISTED
Plum Acquisition Corp. III Class A Ordinary Shares
PLMJ
$6.11M 0.13%
596,765
V icon
219
Visa
V
$701B
$6.07M 0.13%
26,932
+15,116
+128% +$3.36M
SNY icon
220
Sanofi
SNY
$107B
$6.03M 0.13%
+110,887
New +$5.39M
ORIA
221
DELISTED
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
$6.03M 0.13%
589,286
+300
+0.1% +$3.05K
MTVC
222
DELISTED
Motive Capital Corp II
MTVC
$6M 0.13%
574,710
NUE icon
223
Nucor
NUE
$58.3B
$5.97M 0.13%
38,665
-72,241
-65% -$11.5M
FWAC
224
DELISTED
Fifth Wall Acquisition Corp. III Class A Ordinary Shares
FWAC
$5.97M 0.13%
584,264
RCAC
225
DELISTED
Revelstone Capital Acquisition Corp. Class A Common Stock
RCAC
$5.96M 0.13%
580,648

Similar funds

Cantor Fitzgerald's Q1 2023 Portfolio in Review

As of Q1 2023, Cantor Fitzgerald held 850 positions worth $4.71B, up 1.1% from $4.65B the previous quarter. Its ten largest holdings account for 15% of the portfolio.

Cantor Fitzgerald withdrew a net $971M in Q1 2023, closing 179 positions and reducing 185 holdings. Its most notable exit was AstraZeneca, an estimated $37.6M position sold in full.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

Against the trend, Cantor Fitzgerald opened a new position in Zimmer Biomet worth $19.8M.

  • Cantor Fitzgerald's largest Q1 2023 buy was Zimmer Biomet: 153,493 shares worth $19.8M.
  • Cantor Fitzgerald added most to Battery Future Acquisition Corp. in Q1 2023, an estimated $28.6M increase.
  • Cantor Fitzgerald's biggest Q1 2023 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $935M.
  • Cantor Fitzgerald fully exited AstraZeneca in Q1 2023, selling an estimated $37.6M.
  • Cantor Fitzgerald's ten largest holdings make up 15% of its $4.71B portfolio in Q1 2023.
  • Cantor Fitzgerald opened 129 new positions and closed 179 in Q1 2023.
  • Cantor Fitzgerald's portfolio value rose 1.1% quarter-over-quarter to $4.71B.

Based on Cantor Fitzgerald's 13F filing for Q1 2023, filed 15 May 2023.